Franklin P Bymaster
VP, Neuroscience at Orexigen Therapeutics, Inc.
Filed with the SEC as BYMASTER FRANKLIN P
- Sold, on record
- $144k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Aug 27, 2008
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 1
- Filed as an executive or holder
Companies
- Orexigen Therapeutics, Inc.VP, Neuroscience
Sales by reason
0
Routine
0
Plan not stated
0
No plan
2
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Aug 27, 2008Unusual
Sold 100% of their holdings
$83k6,938 shares at $12.00
- Aug 25, 2008Unusual
Sold 100% of their holdings
$60k5,041 shares at $12.00
2 of 2
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2008 | Aug 29, 2008 | Orexigen Therapeutics, Inc. | VP, Neuroscience | Sold | 6,938 | $12.00 | $83k | 0 | SEC |
| Aug 27, 2008 | Aug 29, 2008 | Orexigen Therapeutics, Inc. | VP, Neuroscience | Exercised or settledCommon Stock (right to buy) | 6,938 | 13,021 | SEC | ||
| Aug 27, 2008 | Aug 29, 2008 | Orexigen Therapeutics, Inc. | VP, Neuroscience | Exercised options | 6,938 | $2.00 | $14k | 6,938 | SEC |
| Aug 25, 2008 | Aug 25, 2008 | Orexigen Therapeutics, Inc. | VP, Neuroscience | Sold | 5,041 | $12.00 | $60k | 0 | SEC |
| Aug 25, 2008 | Aug 25, 2008 | Orexigen Therapeutics, Inc. | VP, Neuroscience | Exercised or settledCommon Stock (right to buy) | 5,041 | 19,959 | SEC | ||
| Aug 25, 2008 | Aug 25, 2008 | Orexigen Therapeutics, Inc. | VP, Neuroscience | Exercised options | 5,041 | $2.00 | $10k | 1,800 | SEC |
| Aug 15, 2008 | Aug 18, 2008 | Orexigen Therapeutics, Inc. | VP, Neuroscience | AwardedStock Option (right to buy) | 10,000 | 10,000 | SEC | ||
| Dec 20, 2007 | Dec 26, 2007 | Orexigen Therapeutics, Inc. | VP of Neuroscience | AwardedStock Option (right to buy) | 4,000 | 4,000 | SEC |
Sales and notices (2)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2008 | Aug 29, 2008 | Orexigen Therapeutics, Inc. | VP, Neuroscience | Form 4 sale | 6,938 | $83k | 100.0% | Unusual | SEC |
| Aug 25, 2008 | Aug 25, 2008 | Orexigen Therapeutics, Inc. | VP, Neuroscience | Form 4 sale | 5,041 | $60k | 100.0% | Unusual | SEC |